Ramy Farid Ph.D.
Net Worth
Last updated:
What is Ramy Farid Ph.D. net worth?
The estimated net worth of Dr. Ramy Farid Ph.D. is at least $9,828,525 as of 4 Jan 2023. He owns shares worth $3,555,849 as insider, has earned $1,222,676 from insider trading and has received compensation worth at least $5,050,000 in Schrödinger, Inc..
What is the salary of Ramy Farid Ph.D.?
Dr. Ramy Farid Ph.D. salary is $1,010,000 per year as Chief Executive Officer, Pres & Director in Schrödinger, Inc..
How old is Ramy Farid Ph.D.?
Dr. Ramy Farid Ph.D. is 61 years old, born in 1964.
What stocks does Ramy Farid Ph.D. currently own?
As insider, Dr. Ramy Farid Ph.D. owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Schrödinger, Inc. (SDGR) | Chief Executive Officer, Pres & Director | 184,432 | $19.28 | $3,555,849 |
What does Schrödinger, Inc. do?
Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences industry, as well as to customers in materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.
Ramy Farid Ph.D. insider trading
Schrödinger, Inc.
Dr. Ramy Farid Ph.D. has made 4 insider trades between 2020-2023, according to the Form 4 filled with the SEC.
The largest trade he's ever made was exercising 80,000 units of SDGR stock on 12 Aug 2020. As of 4 Jan 2023 he still owns at least 184,432 units of SDGR stock.
Schrödinger key executives
Schrödinger, Inc. executives and other stock owners filed with the SEC:
- Dr. Karen Akinsanya Ph.D. (57) Executive Vice President, Chief Biomedical Scientist and Head of Discovery R&D
- Dr. Ramy Farid Ph.D. (61) Chief Executive Officer, Pres & Director
- Dr. Richard A. Friesner (72) Co-Founder, Scientific Advisory Chairman and Director
- Ms. Yvonne Tran Esq. (55) Executive Vice President, Chief Legal Officer & Sec.